PurposeThe objective of the study was to evaluate the synergistic transdermal permeation effect of chemical enhancers and iontophoresis technique on tolterodine tartrate (TT) transdermal gel and to evaluate its pharmacokinetic properties.Materials and MethodsTaguchi robust design was used for optimi...

Full description

Bibliographic Details
Main Authors:	D. Prasanthi, P. K. Lakshmi
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2013-01-01
Series:	International Brazilian Journal of Urology
Subjects:	Iontophoresis Administration, Cutaneous tolterodine [Supplementary Concept] Urinary Bladder, Overactive
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382013000100063

Similar Items

Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder
by: D. Prasanthi, et al.
Published: (2013-01-01)

The effect of extended release tolterodine used for overactive bladder treatment on female sexual function
by: Athanasios Zachariou, et al.

Clinical Experience of the Use of Tolterodine in Patients with Overactive Bladder at Siriraj Hospital
by: Vitaya Titapant, et al.
Published: (2020-08-01)

Comparison of efficacy and side-effects of Oxybutynin and Tolterodine in the treatment of overactive bladder
by: Ghanbari Z, et al.
Published: (2011-08-01)

The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
by: Danny Ulahannan, et al.
Published: (2009-04-01)

Clinical and urodynamic effects of tolterodine in women with an overactive bladder
by: Chiu-Lin Wang, et al.
Published: (2013-09-01)

Solifenacin and Tolterodine are Equally Effective in the Treatment of Overactive Bladder Symptoms
by: Chen-Hsun Ho, et al.
Published: (2010-10-01)

Efficacy and safety of tolterodine in subjects with symptoms of overactive bladder: An open label, noncomparative, prospective, multicentric study
by: Anant Kumar
Published: (2002-01-01)

Solifenacin in overactive bladder syndrome: pharmacoeconomic analysis
by: Sergio Iannazzo, et al.
Published: (2008-03-01)

Sphingosine Kinase 1 urothelial expression is increased in patients with neurogenic detrusor overactivity
by: Quentin Ballouhey, et al.
Published: (2015-12-01)

Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation
by: Rajabalaya Rajan, et al.
Published: (2017-09-01)

Efficacy and tolerability of mirabegron in female patients with overactive bladder symptoms after surgical treatment for stress urinary incontinence
by: Mete Özkidik, et al.

Transdermal drug delivery treatment for overactive bladder
by: Roger R. Dmochowski, et al.
Published: (2006-10-01)

Prominent Complaint: a Guide to Medical Therapy of Overactive Bladder Syndrome in Older Women
by: Mina Jafarabadi, et al.
Published: (2015-02-01)

Posterior Tibial Nerve Stimulation for Treating Neurologic Bladder in Women: a Randomized Clinical Trial
by: Tahereh Eftekhar, et al.
Published: (2014-11-01)

Efficacy and safety of propiverine and terazosine combination for one year in male patients with luts and detrusor overactivity
by: Nevzat Can Sener, et al.
Published: (2013-07-01)

Dose and aging effect on patients reported treatment benefit switching from the first overactive bladder therapy with tolterodine ER to fesoterodine: post-hoc analysis from an observational and retrospective study
by: Castro-Diaz David, et al.
Published: (2012-07-01)

Changing concepts in the diagnosis and management of overactive bladder
by: Hari Siva Gurunadha Rao Tunuguntla, et al.
Published: (2001-01-01)

Συγκριτική ουροδυναμική αξιολόγηση της δραστικότητας της οξυβουτυνίνης και τολτεροδίνης στην ιδιοπαθή υπερδραστήρια κύστη : συσχετισμός με το βαθμό ουροδυναμικής βαρύτητας της υπερδραστηριότητας και το "δείκτη υπερδραστηριότητας"
by: Γιαννίτσας, Κωνσταντίνος
Published: (2009)

Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER)
by: Sender Herschorn, et al.
Published: (2018-04-01)

Overactive bladder syndrome and bladder wall thickness in patients with obstructive sleep apnea syndrome
by: Zahide Yilmaz, et al.

Detrusor after-contraction: a new insight
by: Françoise A. Valentini, et al.
Published: (2015-06-01)

Increased Bladder Wall Thickness in Diabetic and Nondiabetic Women With Overactive Bladder
by: Hakkı Uzun, et al.
Published: (2013-06-01)

Intravesical Sodium Chondroitin Sulphate to Treat Overactive Bladder: Preliminary Result
by: Lokman Irkilata, et al.
Published: (2015-06-01)

OAB score: A clinical model that predicts the probability of presenting overactive detrusor in the urodynamic study
by: Leandro Cristian Arribillaga, et al.

Effectiveness of Retropubic Tension-Free Vaginal Tape and Transobturator Inside-Out Tape Procedures in Women With Overactive Bladder and Stress Urinary Incontinence
by: Ji-Yeon Han, et al.
Published: (2013-09-01)

Development of an Improved Animal Model of Overactive Bladder: Transperineal Ligation versus Transperitoneal Ligation in Male Rats
by: Woo Hyun Kim, et al.
Published: (2016-08-01)

The role of bladder diverticula in the prevalence of acute urinary retention in patients with BPH who are candidates to surgery
by: Alexandre Iscaife, et al.

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

Seasonal Variation of Drug Prescription Rate for Overactive Bladder in Men Based on National Health Insurance Claims Data, 2012–2016
by: Jong Won Kim, et al.
Published: (2020-09-01)

Recurring priapism may be a symptom of voiding dysfunction – case report and literature review
by: Lisieux Eyer de Jesus, et al.
Published: (2016-04-01)

Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
by: Maryam Emami, et al.

Impact of overactive bladder on retrograde ejaculation
by: Ahmet Salvarci, et al.

The Prevalence and Therapeutic Effect of Constipation in Pediatric Overactive Bladder
by: Ji Hyun Kim, et al.
Published: (2011-12-01)

Dissimilar Effects of Tolterodine on Detrusor Overactivity in Awake Rats with Chemical Cystitis and Partial Bladder Outlet Obstruction
by: Long-Hu Jin, et al.
Published: (2011-09-01)

Additional low-dose antimuscarinics can improve overactive bladder symptoms in patients with suboptimal response to beta 3 agonist monotherapy
by: Jung Hyun Shin, et al.
Published: (2017-07-01)

The Impact of Overactive Bladder on Health-Related Quality of Life, Sexual Life and Psychological Health in Korea
by: Eun Sang Yoo, et al.
Published: (2011-09-01)

Urethral pressure variation: a neglected contributing factor in patients with overactive bladder syndrome?
by: Ruth Kirschner-Hermanns, et al.

Potential Biomarkers for Diagnosis of Overactive Bladder Patients: Urinary Nerve Growth Factor, Prostaglandin E2, and Adenosine Triphosphate
by: Yoon Seok Suh, et al.
Published: (2017-09-01)

Assessment of Proportion of Hidden Patients Having Symptoms of Overactive Bladder and Why Has It Been Hidden in Female Outpatients Admitted to Hospital
by: Oktay Üçer, et al.
Published: (2016-03-01)